Merck avoided billions in U.S. tax by offshoring Keytruda profits - senator
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Merck (MRK) Tops Analyst Estimates on Strong Keytruda, Gardasil, and Bridion Sales
July 28, 2022 2:03 PM EDTMerck's (NYSE: MRK) shares dipped in the early part of Thursday's session after it reported second-quarter earnings.
Profit and revenue topped analyst expectations, but the company's shares fell as low as $87.42 after guidance disappointed investors. The stock has since regained the majority of its initial losses.
Merck posted earnings of $1.87, $0.19 better than the analyst estimate of... More
